Telehealth Groups Urge DEA for Remote Prescription Plan Before Year-End
Healthcare Dive
|
Contributed by: Kate Gamble
Summary
Over 200 telehealth and provider organizations are calling on the DEA to develop a plan for remote prescriptions of controlled substances before current pandemic-era flexibilities expire at the year's end. These regulations have been crucial in enhancing patient access to care, particularly for those in underserved areas. The Biden administration's previous proposals faced criticism for excessive regulatory burdens, highlighting the need for collaboration with industry experts to ensure effective telehealth policies. As the DEA considers new regulations for prescribing controlled substances via telehealth, finding a balance between access and preventing drug misuse remains essential for healthcare providers.
